Growth hormone secretory pattern in non-obese children and adolescents with Prader-Willi syndrome

Journal of Pediatric Endocrinology and Metabolism

Volumn 24, Issue 7-8, 2011, Pages 477-481

  Grugni, Graziano ^a   Crinò, Antonino ^b   Pagani, Sara ^c   Meazza, Cristina ^c   Buzi, Fabio ^d   De Toni, Teresa ^e   Gargantini, Luigi ^f   Pilotta, Alba ^d   Pozzan, Giovanni B ^g   Radetti, Giorgio ^h   Ragusa, Letizia ⁱ   Salvatoni, Alessandro ^j   Sartorio, Alessandro ^a   Bozzola, Mauro ^c  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d UNIVERSITY OF BRESCIA   (Italy)

^e UNIVERSITY OF GENOA   (Italy)

^f Civic Hospital   (Italy)

^g UNIVERSITY OF PADOVA   (Italy)

^h CENTRAL HOSPITAL OF BOLZANO   (Italy)

ⁱ OASI RESEARCH INSTITUTE IRCCS   (Italy)

^j UNIVERSITY OF INSUBRIA   (Italy)

more..

Author keywords

GH bioactivity; GH deficiency; obesity; Prader Willi syndrome

Indexed keywords

ARGININE; GROWTH HORMONE; SOMATOMEDIN C;

ADOLESCENT; ARTICLE; BODY MASS; CHILD; CHROMOSOME 15Q; CHROMOSOME DELETION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HUMAN; IMMUNOFLUORESCENCE TEST; MALE; PRADER WILLI SYNDROME; PRESCHOOL CHILD; PROVOCATION TEST; SCHOOL CHILD;

ADOLESCENT; ARGININE; BODY MASS INDEX; CELL LINE, TUMOR; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; FEMALE; FLUOROIMMUNOASSAY; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LYMPHOMA; MALE; OBESITY; PRADER-WILLI SYNDROME; PROLACTIN; REPRODUCIBILITY OF RESULTS; SECRETORY RATE;

EID: 80052010891     PISSN: 0334018X     EISSN: 21910251     Source Type: Journal    
DOI: 10.1515/JPEM.2011.269     Document Type: Article

References (27)

1. Whittington JE, Holland AJ, Webb T, Butler J, Clarke D, et al. Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region. J Med Genet 2001;38:792-8.
2. Bittel DC, Butler MG. Prader-Willi syndrome. Clinical genetics, cytogenetics and molecular biology. Expert Rev Mol Med 2005;7:1-20.
3. Goldstone AP. Prader-Willi syndrome: Advances in genetics, pathophysiology and treatment. Trends Endocrinol Metab 2004;15:12-20.
4. Lee PD, Allen DB, Angulo MA, Cappa M, Carrel AL, et al. Consensus statement-Prader-Willi syndrome: Growth hormone (GH)/insulin-like growth factor axis defi ciency and GH treatment. Endocrinologist 2000;10(Suppl 1-4):71S-74S.
5. Burman P, Ritzen EM, Lindgren AC. Endocrine dysfunction in Prader-Willi syndrome: A review with special reference to GH. Endocr Rev 2001;22:787-99.
6. Goldstone AP, Holland AJ, Hauffa BP, Hokken-Koelega AC, Tauber M; speakers contributors at the Second Expert Meeting of the Comprehensive Care of Patients with PWS: Accadbled F, Cavaillé J, Rogé B, Sales de Gauzy J, Blichfeldt S, Butler MG, Carrel AL, Chiumello G, Curfs LM, Schrander-Stumpel CT, Driscoll DJ, Miller JL, Gourash LM, Nicholls RD, Grugni G, Heinemann J, H ö ybye C, Lindgren AC, Ritzen M, Muscatelli F, Nagai T, Nijhuijs MW, Odent T, Schl ü ter B, Soni S, Whittington J, Swaab DF, Thuilleaux D, Vogels A, Whitman BY, Wilton P. Recommendations for the diagnosis and management of Prader- Willi syndrome. J Clin Endocrinol Metab 2008;93:4183-97.
7. Tauber M, Barbeau C, Jouret B, Pienkowski C, Malzac P, et al. Auxological and endocrine evolution of 28 children with Prader- Willi syndrome: Effect of GH therapy in 14 children. Horm Res 2000;53:279-87.
8. Kokkoris P, Pi-Sunyer FX. Obesity and endocrine diseases. Endocrinol Metab Clin North Am 2003;32:895-914.
9. Kreitschmann-Andermahr I, Suarez P, Jennings R, Evers N, Brabant G. GH/IGF-I regulation in obesity-mechanisms and practical consequences in children and adults. Horm Res Paediatr 2010;73:153-60.
10. Angulo M, Castro-Magana M, Mazur B, Canas JA, Vitollo PM, et al. Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome. J Pediatr Endocrinol Metab 1996;9:393-400.
11. Costeff H, Holm VA, Ruvalcaba R, Shaver J. Growth hormone secretion in Prader-Willi syndrome. Acta Paediatr Scand 1990;79:1059-62.
12. Holm VA, Cassidy SB, Butler MG, Hanchett JM, Greenswag LR, et al. Prader-Willi syndrome: Consensus diagnostic criteria. Pediatrics 1993;91:398-402.
13. Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. Arch Dis Child 1966;41:613-35.
14. Cacciari E, Milani S, Balsamo A, Spada E, Bona G, et al. Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest 2006;29:581-93.
15. Marshall WA, Tanner JM. Variation in the pattern of pubertal changes in girls. Arch Dis Child 1969;44:291-303.
16. Marshall WA, Tanner JM. Variation in the pattern of pubertal changes in boys. Arch Dis Child 1970;45:13-23.
17. Tanaka T, Shiu RPC, Gout PJ, Beer CT, Noble RL, et al. A new sensitive and specific bioassay for lactogenic hormones: Measurement of prolactin and growth hormone in human serum. J Clin Endocrinol Metab 1980;51:1058-63.
18. Walker A, Croze F, Friesen HG. A serum-free medium for culturing lactogen dependent and autonomous Nb2 node lymphoma cells. Endocrinology 1987;120:2389-97.
19. Bozzola M, Zecca M, Locatelli F, Radetti G, Pagani S, et al. Evaluation of growth hormone bioactivity using the Nb 2 cell bioassay in children with growth disorders. J Endocrinol Invest 1998;21:765-70.
20. Carrel AL, Lee PDK, Mogul HR. Growth hormone and Prader- Willi syndrome. In: Butler MG, Lee PDK, Whitman BY, editors. Management of Prader-Willi syndrome, 3rd ed. New York: Springer, 2006:201-41.
21. Lindgren AC, Lindberg A. Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: Experience from KIGS (Pfi zer International Growth Database). Horm Res 2008;70:182-7.
22. Theodoro MF, Talebizadeh Z, Butler MG. Body composition and fatness patterns in Prader-Willi syndrome: Comparison with simple obesity. Obesity 2006;14:1685-90.
23. Brambilla P, Bosio L, Manzoni P, Pietrobelli A, Beccaria L, et al. Peculiar body composition in patients with Prader-Labhart-Willi. Am J Clin Nutr 1997;65:1369-74.
24. Eiholzer U, l'Allemand D, Schlumpf M, Rousson V, Gasser T, et al. Growth hormone and body composition in children younger than 2 years with Prader-Willi syndrome. J Pediatr 2004;144: 753-8.
25. Colmenares A, Pinto G, Taupin P, Giuseppe A, Odent T, et al. Effects on growth and metabolism of growth hormone treatment for 3 years in 36 children with Prader-Willi syndrome. Horm Res Paediatr 2011;75:123-30.
26. H ö ybye C. Five-years growth hormone (GH) treatment in adults with Prader-Willi syndrome. Acta Paediatr 2007;96:410-3.
27. Grugni G, Crin ó A, Bertocco P, Marzullo P. Body fat excess and stimulated growth hormone levels in adult patients with Prader- Willi syndrome. Am J Med Genet A 2009;149:726-31.